Drug
Jtt 861
Jtt 861: highest development phase Phase 2, developed by Shionogi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Shionogi
Trials
| Drug | Phase | Indication |
|---|---|---|
| JTT-861 Capsules NCT06017609 | Phase 2 | Chronic Heart Failure |
Latest
No recent events.
Follow Jtt 861 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.